Home
4D pharma plc

4D pharma plc Market Share Analysis for March 2026

we understand that the bacteria of the gut microbiome have an important function in health and disease, but importantly – we understand how they function, and how they could be used as potential new therapies.

Health > Biotechnology and Pharmaceuticals

Domain4dpharmaplc.com

Year Founded2014

Employees51 - 200

Annual Revenue< $1M

4D pharma plc

4D pharma plc (including company regionals)

4dpharmaplc.com

See more website traffic and engagement information

Total visits to 4D pharma plc's top domains

Understand 4D pharma plc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

4dpharmaplc.com330

See more with Sales Intelligence

Avg. visit duration in 4D pharma plc's top domains

Analyze 4D pharma plc engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on 4D pharma plc's top domains

See how 4D pharma plc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

4dpharmaplc.com1.01

See more with Sales Intelligence

4D pharma plc top competitors by domain

Top similar sites in March 2026, ranked by their affinity

protexin.comCompany NameProtexinEmployees51 - 200HQUnited Kingdom, South PethertonAnnual revenue$25M - $50MTotal visits50.5KHealth > Health - Other

Top technologies used by 4D pharma plc

These are the website technologies, by industry, used by 4D pharma plc top domains

Conversion & Analytics (3)

Google Analytics

Marketing (3)

Google Marketing Platform

Advertising (2)

DoubleClick

Email Services (2)

Sendgrid

More Technologies

5

See all

News & Signals from 4D pharma plc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCJ Bioscience, Inc. acquired 4dpharmaplc on Mar 1st '23.In March, CJ Bioscience acquired all candidate materials from 4D Pharma PLC, a UK-based leader in microbiome-based anticancer drug development.

News4dpharmaplc is developing Blautix.4D Pharma is developing Blautix, an orally administered drug.

News4dpharmaplc is developing live therapeutic products for a range of disease areas.UK-based 4D Pharma is harnessing the power of the gut microbiome to develop live therapeutic products for a range of disease areas, including cancer and neurodegeneration.